Trials / Completed
CompletedNCT03257436
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 586 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Prospective, multi-center, single arm, post approval study to be conducted in the United States.
Detailed description
Evaluate the effectiveness of Boston Scientific (BSC)'s LV MSP (Left Ventricular MultiSite Pacing) feature in the Resonate family of CRT-D devices and confirm safety in a post approval study when used in accordance with its approved labeling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CRT-D | Left Ventricular MultiSite Pacing |
Timeline
- Start date
- 2018-01-05
- Primary completion
- 2020-11-19
- Completion
- 2020-11-19
- First posted
- 2017-08-22
- Last updated
- 2022-01-03
- Results posted
- 2022-01-03
Locations
54 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03257436. Inclusion in this directory is not an endorsement.